{"transactions":[{"id":1435142,"issuer":{"id":5982,"kind":"organization","name":"NORTHWEST BIOTHERAPEUTICS INC"},"owners":[{"id":88350,"kind":"person","name":"BOSCH MARNIX L","position":1,"cik":"0001253933","reported_name":"BOSCH MARNIX L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OFFICER"}}],"security":"STOCK OPTIONS","published_at":"2024-08-13T20:01:24.000Z","date":"2024-08-09","kind":"gift","planned":false,"acquired":false,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"GIFT FROM DR. BOSCH TO FAMILY MEMBERS WHO DO NOT SHARE SAME RESIDENCE FOR ESTATE PLANNING PURPOSES"}],"balance_after":4549157,"derivative":{"exercise_price":0.35,"exercise_date":"2020-07-02","expiration_date":"2030-07-02","underlying":"COMMON STOCK PAR VALUE $0.001","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001104659-24-088927","document":"tm2421584-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1072379/000110465924088927/tm2421584-1_4seq1.xml","form_type":"4"}},{"id":1925520,"issuer":{"id":5982,"kind":"organization","name":"NORTHWEST BIOTHERAPEUTICS INC"},"owners":[{"id":88350,"kind":"person","name":"BOSCH MARNIX L","position":1,"cik":"0001253933","reported_name":"BOSCH MARNIX L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2023-04-05T23:31:28.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":119355,"price":0.25,"value":29838.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 3, 2023, Dr. Bosch was issued 119,355 shares of the Company's common stock pursuant to his exercise of certain options that were awarded in 2017."}],"balance_after":119355,"source":{"system":"sec-edgar","filing":"0001104659-23-042303","document":"tm2311932-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1072379/000110465923042303/tm2311932-1_4seq1.xml","form_type":"4"}},{"id":3092684,"issuer":{"id":5982,"kind":"organization","name":"NORTHWEST BIOTHERAPEUTICS INC"},"owners":[{"id":88350,"kind":"person","name":"BOSCH MARNIX L","position":1,"cik":"0001253933","reported_name":"BOSCH MARNIX L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Options to purchase Common Stock, par value $0.001","published_at":"2020-07-03T01:55:48.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":16630726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These options were awarded in part for service during the last 2 years. However, the documents to implement and issue (grant) them have not been executed until now. The $0.25 exercise price was determined with reference to the pricing for unrelated investors at the time of approval, which was the trailing 10-day average closing market price of the Company's stock, which was about $0.22. These options are subject to certain vesting requirements. They are also suspended and will not become exercisable until December 1, 2020."}],"balance_after":16630726,"derivative":{"exercise_price":0.25,"exercise_date":"2020-12-01","expiration_date":"2030-12-01","underlying":"Common Stock, par value $0.001","underlying_shares":16630726},"source":{"system":"sec-edgar","filing":"0001104659-20-080809","document":"tm2022243d9_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1072379/000110465920080809/tm2022243d9_4.xml","form_type":"4"}},{"id":3092683,"issuer":{"id":5982,"kind":"organization","name":"NORTHWEST BIOTHERAPEUTICS INC"},"owners":[{"id":88350,"kind":"person","name":"BOSCH MARNIX L","position":1,"cik":"0001253933","reported_name":"BOSCH MARNIX L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Options to purchase Common Stock, par value $0.001","published_at":"2020-07-03T01:55:48.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":3249572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These options were approved in January 2020.  The exercise price was determined based upon the pricing in year-end financings with unrelated investors.  However, these options have not been executed and implemented (granted) until now."}],"balance_after":3249572,"derivative":{"exercise_price":0.21,"exercise_date":"2020-07-02","expiration_date":"2030-07-02","underlying":"Common Stock, par value $0.001","underlying_shares":3249572},"source":{"system":"sec-edgar","filing":"0001104659-20-080810","document":"tm2022243d10_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1072379/000110465920080810/tm2022243d10_4.xml","form_type":"4"}},{"id":3092682,"issuer":{"id":5982,"kind":"organization","name":"NORTHWEST BIOTHERAPEUTICS INC"},"owners":[{"id":88350,"kind":"person","name":"BOSCH MARNIX L","position":1,"cik":"0001253933","reported_name":"BOSCH MARNIX L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Options to purchase Common Stock, par value $0.001","published_at":"2020-07-03T01:55:48.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":7549157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These options were already approved and publicly reported in 2018. The exercise price was determined with reference to the pricing for unrelated investors at that time. However, the documents to implement and issue (grant) them have not been executed until now."}],"balance_after":7549157,"derivative":{"exercise_price":0.25,"exercise_date":"2020-07-02","expiration_date":"2030-07-02","underlying":"Common Stock, par value $0.001","underlying_shares":7549157},"source":{"system":"sec-edgar","filing":"0001104659-20-080810","document":"tm2022243d10_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1072379/000110465920080810/tm2022243d10_4.xml","form_type":"4"}},{"id":4270343,"issuer":{"id":5982,"kind":"organization","name":"NORTHWEST BIOTHERAPEUTICS INC"},"owners":[{"id":88350,"kind":"person","name":"BOSCH MARNIX L","position":1,"cik":"0001253933","reported_name":"BOSCH MARNIX L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-06-29T20:25:57.000Z","date":"2017-06-13","kind":"exercise","acquired":true,"shares":7940182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option's vesting schedule is as follows: 50% vested upon the date of grant with the remaining 50% vesting over a 24-month period in equal monthly installments"}],"balance_after":7940182,"derivative":{"exercise_price":0.25,"expiration_date":"2022-06-13","underlying":"Common Stock","underlying_shares":7940182},"source":{"system":"sec-edgar","filing":"0001144204-17-034899","document":"v469635_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1072379/000114420417034899/v469635_4.xml","form_type":"4"}}]}